Literature DB >> 11487568

The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism.

K Hedrich1, M Kann, A J Lanthaler, A Dalski, C Eskelson, O Landt, E Schwinger, P Vieregge, A E Lang, X O Breakefield, L J Ozelius, P P Pramstaller, C Klein.   

Abstract

Early-onset parkinsonism (EOP) may be associated with different mutations in the parkin gene, including exon deletions and duplications. To test for gene dosage alterations, we developed a new method of quantitative duplex PCR using the fluorescence resonance energy transfer technique on the LightCycler (Roche Diagnostics). In 21 patients with EOP, three mutations (a single base pair substitution in exon 3 and small deletions in exon 9) were detected by conventional mutational screening (single-strand conformation polymorphism and sequence analysis), while alterations of gene dosage were found in seven patients. We identified heterozygous and compound heterozygous deletions of exons 2, 3, 5 and 7. The latter was also found in the homozygous state. In addition, two heterozygous duplications of exon 4 were observed. Remarkably, two patients carried more than two parkin mutations. This is the first study systematically screening all 12 exons of parkin by real-time, kinetic quantification and clearly shows that mutational analysis of the parkin gene should include gene dosage studies. Furthermore, our method of quantitative PCR is easily applicable to any other gene to be screened for deletions or duplications of whole exons.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487568     DOI: 10.1093/hmg/10.16.1649

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  23 in total

1.  Blink amplitude but not saccadic hypometria indicates carriers of Parkin mutations.

Authors:  C Helmchen; A Schwekendiek; P P Pramstaller; K Hedrich; C Klein; H Rambold
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

2.  Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study.

Authors:  Elise Caccappolo; Roy N Alcalay; Helen Mejia-Santana; Ming-X Tang; Brian Rakitin; Llency Rosado; Elan D Louis; Cynthia L Comella; Amy Colcher; Danna Jennings; Martha A Nance; Susan Bressman; William K Scott; Caroline M Tanner; Susan F Mickel; Howard F Andrews; Cheryl Waters; Stanley Fahn; Lucien J Cote; Steven Frucht; Blair Ford; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald F Pfeiffer; Laura Marsh; Brad Hiner; Andrew D Siderowf; Barbara M Ross; Miguel Verbitsky; Sergey Kisselev; Ruth Ottman; Lorraine N Clark; Karen S Marder
Journal:  J Int Neuropsychol Soc       Date:  2010-11-24       Impact factor: 2.892

3.  SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and Drosophila.

Authors:  Alessandra Zanon; Sreehari Kalvakuri; Aleksandar Rakovic; Luisa Foco; Marianna Guida; Christine Schwienbacher; Alice Serafin; Franziska Rudolph; Michaela Trilck; Anne Grünewald; Nancy Stanslowsky; Florian Wegner; Valentina Giorgio; Alexandros A Lavdas; Rolf Bodmer; Peter P Pramstaller; Christine Klein; Andrew A Hicks; Irene Pichler; Philip Seibler
Journal:  Hum Mol Genet       Date:  2017-07-01       Impact factor: 6.150

4.  Analysis of exon dosage using MLPA in South African Parkinson's disease patients.

Authors:  Rowena J Keyser; Debbie Lombard; Rene Veikondis; Jonathan Carr; Soraya Bardien
Journal:  Neurogenetics       Date:  2009-12-15       Impact factor: 2.660

5.  Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease.

Authors:  Corinne Lautier; Stefano Goldwurm; Alexandra Dürr; Barbara Giovannone; William G Tsiaras; Gianni Pezzoli; Alexis Brice; Robert J Smith
Journal:  Am J Hum Genet       Date:  2008-03-20       Impact factor: 11.025

6.  Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control.

Authors:  J Brooks; J Ding; J Simon-Sanchez; C Paisan-Ruiz; A B Singleton; S W Scholz
Journal:  J Med Genet       Date:  2009-04-06       Impact factor: 6.318

7.  Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.

Authors:  Jung Mi Choi; Myoung Soo Woo; Hyeo-Il Ma; Suk Yun Kang; Young-Hee Sung; Seok Woo Yong; Sun Ju Chung; Joong-Seok Kim; Hae-won Shin; Chul Hyoung Lyoo; Phil Hyu Lee; Jong Sam Baik; Sang-Jin Kim; Mee Young Park; Young Ho Sohn; Jin-Ho Kim; Jae Woo Kim; Myung Sik Lee; Myoung Chong Lee; Dong-Hyun Kim; Yun Joong Kim
Journal:  Neurogenetics       Date:  2008-08-15       Impact factor: 2.660

Review 8.  Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance.

Authors:  Dena G Hernandez; Xylena Reed; Andrew B Singleton
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

9.  PINK1 mutation in Taiwanese early-onset parkinsonism : clinical, genetic, and dopamine transporter studies.

Authors:  Yi-Hsin Weng; Yah-Huei Wu Chou; Wen-Shiang Wu; Kun-Ju Lin; Hsiu-Chen Chang; Tzu-Chen Yen; Rou-Shayn Chen; Shiaw-Pyng Wey; Chin-Song Lu
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 4.849

Review 10.  Chasing genes in Alzheimer's and Parkinson's disease.

Authors:  Aida M Bertoli-Avella; Ben A Oostra; Peter Heutink
Journal:  Hum Genet       Date:  2004-03-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.